Theratechnologies (THTX) Set to Announce Earnings on Thursday

Theratechnologies (NASDAQ:THTX) is scheduled to be posting its quarterly earnings data before the market opens on Thursday, October 10th. Theratechnologies has set its FY 2024 guidance at EPS.

Theratechnologies (NASDAQ:THTX) last announced its quarterly earnings results on Wednesday, July 10th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.04. The firm had revenue of $22.02 million during the quarter. During the same period last year, the firm earned ($0.40) EPS. On average, analysts expect Theratechnologies to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Theratechnologies Stock Down 1.7 %

Shares of NASDAQ:THTX opened at $1.19 on Thursday. The business’s 50 day moving average is $1.30 and its 200 day moving average is $1.34. The stock has a market cap of $54.72 million, a P/E ratio of -6.26 and a beta of 1.41. Theratechnologies has a 52-week low of $0.88 and a 52-week high of $2.58.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.